ASH 41st (2000)

Title
PRIMARY RENAL NON-HODGKIN'S LYMPHOMA (NHL) AND GLOMERULONEPHRITIS IN NHL AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). (click for details)
HIGH-INTENSITY AUTOTRANSPLANTATION FOLLOWED BY REDUCED-INTENSITY CYTOTOXIC ALLOTRANSPLANTATION REGIMEN (MINI-ALLOGRAFTING). (click for details)
HIGH DOSE CYCLOPHOSPHAMIDE, CARMUSTINE AND ETOPOSIDE FOR NON-HODGKIN'S LYMPHOMA IS A SAFE AND EFFECTIVE CONDITIONING REGIMEN FOR ALLOGENEIC PROGENITOR CELL TRANSPLANT. (click for details)
ALLOGENEIC BONE MARROW TRANSPLANTATION (BMT) FOR HIGH RISK ALL IN FIRST REMISSION (ICR). (click for details)
REPORT ON A RANDOMIZED TRIAL COMPARING CYCLOPHOSPHAMIDE AND CYCLOSPORINE VS ANTITHYMOCYTE GLOBULIN AND CYCLOSPORINE AS INITIAL TREATMENT FOR SEVERE APLASTIC ANEMIA. (click for details)
LESS INTENSE CONDITIONING WITH FLUDARABINE, CYCLOPHOSPHAMH, IDARUBICIN AND ETOPOSIDE FOLLOWED BY ALLOGENEIC PERIPHERAL STEM CELL TRANSPLANTATION IN PATIENTS WITH LEUKEMIA. (click for details)
BRONCHOSCOPY GUIDED BY HIGH-RESOLUTION COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF PULMONARY INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. (click for details)
EFFICACY AND TOXICITY OF CCNU-BASED HIGH DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN RELAPSED OR REFRACTORY HODGKIN'S DISEASE (HD). (click for details)
MULTIVARIATE ANALYSIS OF FACTORS INFLUENCING THE RATE OF DOCUMENTED INFECTIONS IN 592 CYCLES HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION. (click for details)
ANTITHYMOCYTE GLOBULIN FOR THE TREATMENT OF PATIENTS WITH 'LOW RISK' MYELODYSPLASTIC SYNDROMES. (click for details)

Pages

Subscribe to ASH 41st (2000)